[1]Ponikowski P, Voors AA, Anker SD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure [J]. Kardiol Pol, 2016, 74(10): 1037-1147.
[2]Nabeebaccus A, Zheng S, Shah AM. Heart failure-potential new targets for therapy [J]. Br Med Bull, 2016, 119(1): 99-110.
[3]Wu Y, He H, Cheng Z, et al. The role of neuropeptide y and peptide yy in the development of obesity via gut-brain axis [J]. Curr Protein Pept Sci, 2019, 20(7): 750-758.
[4]Aubdool AA, Thakore P, Argunhan F, et al. A novel alpha-calcitonin gene-related peptide analogue protects against end-organ damage in experimental hypertension, cardiac hypertrophy, and heart failure [J]. Circulation, 2017, 136(4): 367-383.
[5]Radi R. Oxygen radicals, nitric oxide, and peroxynitrite: Redox pathways in molecular medicine [J]. Proc Natl Acad Sci USA, 2018, 115(23): 5839-5848.
[6]Saraf R, Mahmood F, Amir R, et al. Neuropeptide y is an angiogenic factor in cardiovascular regeneration [J]. Eur J Pharmacol, 2016, 776:64-70.
[7]Ma Q. Preparation of a model of chronic heart failure induced by adriamycin in rats [J]. Biological Chemical Engineering, 2019, 5(4): 100-103. (in Chinese)
马琴. 阿霉素诱导大鼠慢性心力衰竭模型的制备 [J]. 生物化工, 2019, 5(4): 100-103.
[8]Fukuda K, Kanazawa H, Aizawa Y, et al. Cardiac innervation and sudden cardiac death [J]. Circ Res, 2015, 116(12): 2005-2019.
[9]Raffaelli B, Reuter U. The biology of monoclonal antibodies: focus on calcitonin gene-related peptide for prophylactic migraine therapy [J]. Neurotherapeutics, 2018, 15(2): 324-335.
[10]Kumar A, Supowit S, Potts JD, et al. Alpha-calcitonin gene-related peptide prevents pressure-overload induced heart failure: role of apoptosis and oxidative stress [J]. Physiol Rep, 2019, 7(21): 1-14.
[11]Cueille C, Pidoux E, De Vernejoul MC, et al. Increased myocardial expression of RAMP1 and RAMP3 in rats with chronic heart failure [J]. Biochem Biophys Res Commun, 2002, 294(2): 340-346.
[12]Lacroix JS, Anggard A, Hokfelt T, et al. Neuropeptide y: presence in sympathetic and parasympathetic innervation of the nasal mucosa [J]. Cell Tissue Res, 1990, 259(1): 119-128.
[13]Zeng XZh, Shen HJ, Wang CR, et al. Changes of neuropeptide Y and synapses in hippocampus afterhypoxia preconditioning in mice[J]. Acta Anatomica Sinica, 2011, 42(2): 155-158.(in Chinese)
曾宪智,沈慧娟,王从荣,等. 低氧预适应后小鼠海马神经肽Y及突触的变化 [J]. 解剖学报, 2011, 42(2): 155-158.
[14]Gür D, Sabas M, Akyüz A, et al. Role of sympathetic cotransmitter galanin on autonomic balance in heart failure: an active player or a bystander [J]. Anatol J Cardiol, 2017, 18(4): 281-288.
[15]Benedet PO, Menegatti ACO, Goncalves MC, et al. The therapeutic value of protein (de)nitrosylation in experimental septic shock [J]. Biochim Biophys Acta Mol Basis Dis, 2018, 1864(1): 307-316.
[16]Chen L, Meng K, Su W, et al. The effect of continuous sedation therapy on immunomodulation, plasma levels of antioxidants, and indicators of tissue repair in post-burn sepsis patients [J]. Cell Biochem Biophys, 2015, 73(2): 473-478.
[17]Tsutsui H, Kinugawa S, Matsushima S. Oxidative stress and heart failure [J]. Am J Physiol Heart Circ Physiol, 2011, 301(6): H2181-2190.
[18]Shah A, Passacquale G, Gkaliagkousi E, et al. Platelet nitric oxide signalling in heart failure: role of oxidative stress [J]. Cardiovasc Res, 2011, 91(4): 625-631.
[19]Rajapakse NW, Giam B, Kuruppu S, et al. Impaired l-arginine-nitric oxide pathway contributes to the pathogenesis of resistant hypertension [J]. Clin Sci (Lond), 2019, 133(20): 2061-2067.
|